Stock Market & Financial Investment News

News Breaks July 3, 2012 20:22 EDT CYTK Biotechnology Value Fund reports 9.98% passive stake in Cytokinetics News For CYTK From The Last 14 Days Check below for free stories on CYTK the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 19:07 EDT CYTK On The Fly: After Hours Movers Subscribe for More Information 17:25 EDT CYTK Amgen reports 7.58% stake in Cytokinetics Subscribe for More Information June 13, 2013 07:55 EDT CYTK Cytokinetics price target raised to $3.50 from $2.50 at Needham Subscribe for More Information June 12, 2013 07:39 EDT CYTK Amgen, Cytokinetics announce expansion of license for omecamtiv mecarbil Subscribe for More Information 07:25 EDT CYTK Cytokinetics trading halted, pending news Sign up for a free trial to see the rest of the stories you've been missing.